Tissue-directed antibodies and methods of using the same
US-2024342260-A1 · Oct 17, 2024 · US
Molecules that bind CD180, compositions and methods of use
US9260529B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9260529-B2 |
| Application number | US-201113034144-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 24, 2011 |
| Priority date | Feb 24, 2010 |
| Publication date | Feb 16, 2016 |
| Grant date | Feb 16, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
The present invention provides novel CD180 binding molecules, methods for their identification, and methods for their use.
First claim
Opening claim text (preview).
We claim: 1. An isolated anti-CD180 antibody or an antigen binding fragment thereof, comprising the complete amino acid of SEQ ID NO:2.
Assignees
Inventors
Classifications
comprising a combination of variable region and constant region components · CPC title
against tumor tissues, cells, antigens · CPC title
- C07K16/2896Primary
against molecules with a "CD"-designation, not provided for elsewhere · CPC title
Immunostimulating oligonucleotides, e.g. CpG · CPC title
Immunostimulants · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9260529B2 cover?
- The present invention provides novel CD180 binding molecules, methods for their identification, and methods for their use.
- Who is the assignee on this patent?
- Hayden-Ledbetter Martha, Ledbetter Jeffrey, Univ Washington Ct Commerciali
- What technology area does this patent fall under?
- Primary CPC classification C07K16/2896. Mapped technology areas include Chemistry & Metallurgy.
- When was this patent published?
- Publication date Tue Feb 16 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).